Top 5 Life Science Angel Investors in France in October 2024
A list of 5 angel investors that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.Top 5 Life Science Angel Investors in France in October 2024
Investor | Life Science France investments |
---|---|
Xavier Niel | 1 |
Bernard Majoie | 1 |
Bertrand Jacquelot | 1 |
Andrew Nutter | 1 |
Sebastian Lombardo | 1 |
Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Series A, Funding Round
- France, United States, United Kingdom
Portfolio highlights
- Cube AI — Cube AI boosts back-office logistics efficiency, allowing teams to handle more loads and focus on human relationships.
- Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
- The Mobile-First Company — Early Stage Startup that is Simplifying Business, One App at a Time. Forget about those overcomplicated, pricey software giants. We're building easy, mobile-first tools that actually make sense.
Bernard Majoie - President @ Fournier-Majoie
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more
Investment focus
- E-Commerce, Information Technology, Food and Beverage
- Pre-Seed, Seed, Angel
- France, United States
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more
Investment focus
- Software, SaaS, Biotechnology
- Seed, Pre-Seed, Funding Round
- France, United Kingdom, United States
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Sebastian Lombardo - CEO @ Valtech
Show more
Investment focus
- Apps, Internet, Lifestyle
- Seed
- France, United States
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Social Media
Medical
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Internet
Digital Media
Construction
Manufacturing
Platforms
Mobile Advertising
eSports
Biotechnology
Hospitality
Fitness
Travel
Recruiting
Cannabis
Wine And Spirits
Sports
Medical Device
Crowdfunding
Social
Automotive
Enterprise Software
CleanTech
Transportation
Legal
Mobile Apps
InsurTech
Enterprise
Android
LGBT
Life Science
Theatre
Film
Non Profit
Sporting Goods
Renewable Energy
SaaS
Restaurants
Software
Social Impact
Celebrity
Cryptocurrency
Agriculture (agtech)
Facebook
Media (entertainment)
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
Czech Republic
South Africa
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Morocco
Malta
Mali
Malaysia
Italy
Peru
Africa
Lithuania
Myanmar
Lebanon
Kuwait
Cayman Islands
Qatar
Cambodia
Israel
Panama
Europe
Mexico
Kazakhstan
Liberia
Jersey
Philippines
Norway
LATAM
Mauritius
Middle East
Kenya
Liechtenstein
Sri Lanka
Nicaragua
Turkey
Serbia
Rwanda
El Salvador
Venezuela
Ukraine
Asia
Portugal
Sierra Leone
Armenia
Zimbabwe
Sweden
Vietnam
Taiwan
Senegal
Uruguay
Uganda
Tunisia
San Marino
Slovenia
Zambia
Uzbekistan
Russian Federation
Seychelles
Thailand
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
Dominican Republic
China
Nigeria
Azerbaijan
Namibia
Japan
Iceland
Iraq
Bahamas
Saudi Arabia
United Arab Emirates
Honduras
Brazil
Bolivia
Isle of Man
Luxembourg
Oceania
Albania
Pakistan
Latvia
Grenada
Jordan
Romania
Argentina
Bangladesh
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Angel Investors in France by industry
Crowdfunding
Venture Capital
Fitness
Restaurants
Cryptocurrency
Finance
Video Games
Organic Food
Wine And Spirits
Photography
Education
Wellness
Medical Device
Email
Social Media
Internet
Social Network
Digital Media
Manufacturing
Mobile
Art
Android
Blockchain
Software
Legal
Construction
Sports
Hospitality
Enterprise Software
Music
InsurTech
Travel
Biotechnology
Recruiting
Platforms
FinTech
Consumer
Enterprise
EdTech
Health Care
Energy
Sustainability
Proptech
SaaS
Hardware
Marketplace
Community
Mobile Apps
Retail
Infrastructure
Fashion
Beauty
Web3
B2B
Impact
Food and Beverage
Payments
Financial Services
Artificial intelligence
Real Estate
Publishing
Big Data
Gaming
Medical
Life Science
Agriculture (agtech)
Transportation
Media (entertainment)
Renewable Energy
Biotech
Automotive
Climate